
U.S.-listed shares of Atai Life Sciences ATAI.O down 22% to $1.99 in extended trading on stock sale news
German-based depression drug developer commences $55 mln stock offering
Co intends to use net offering proceeds for general purposes, including to advance clinical development of product candidates and programs
Berenberg sole bookrunner
Co has 167.8 mln shares outstanding, giving it a ~$428 mln market cap
ATAI shares finished up 14.3% at $2.55 on Weds. Stock ended 2024 at $1.33